Suchergebnisse - "Katsila, Theodora"

PubPharm (5)

1

Genomic variants in members of the Krüppel-like factor gene family are associated with disease severity and hydroxyurea treatment efficacy in β-hemoglobinopathies patients

enthalten in: Pharmacogenomics | 2019

von Stratopoulos, A. | Kolliopoulou, A. | Karamperis, K. | +15

2

Role of Genomic Biomarkers in Increasing Fetal Hemoglobin Levels Upon Hydroxyurea Therapy and in β-Thalassemia Intermedia : A Validation Cohort Study

enthalten in: Hemoglobin | 2019

von Kolliopoulou, A. | Siamoglou, S. | John, A. | +10

3

Whole transcriptome analysis of human erythropoietic cells during ontogenesis suggests a role of VEGFA gene as modulator of fetal hemoglobin and pharmacogenomic biomarker of treatment response to hydroxyurea in β-type hemoglobinopathy patients

enthalten in: Human genomics | 2017

von Chondrou, V. | Kolovos, P. | Sgourou, A. | +9

4

Functional Analysis of an (A)γ-Globin Gene Promoter Variant (HBG1 : g.-225_-222delAGCA) Underlines Its Role in Increasing Fetal Hemoglobin Levels Under Erythropoietic Stress

enthalten in: Hemoglobin | 2016

von Ugrin, M. | Stojiljkovic, M. | Zukic, B. | +7

5

Individualizing fetal hemoglobin augmenting therapy for β-type hemoglobinopathies patients

enthalten in: Pharmacogenomics | 2014

von Gravia, A. | Chondrou, V. | Sgourou, A. | +5

1
[1]